Termoterapia transpupilar en neovascularización subretiniana oculta secundaria a degeneración macular asociada a la edad. Primeros resultados

To determine the efficacy of transpupillary thermotherapy (TTT) to treat choroidal neovascularization (CNV) in patients with age-related macular degeneration (ARMD). Patients and Methods: Eight patients (ten eyes) with occult CNV were treated by TTT. A 810 nm diode laser was used to perform TTT. The...

ver descrição completa

Detalhes bibliográficos
Autores: Salinas-Alaman, A. (Ángel)|||/items/ac6c3088-aae2-4d82-97b0-d087742c1901, Garcia-Layana, A. (Alfredo)|||/items/631fff44-be4e-42e5-ad3a-8f0f10305836, Juberias, J.R. (J. R.)|||/items/995e894d-c46b-4ec2-98fe-071dd3b1cec8, Sanchez-Tocino, H. (Hortensia)|||/items/dfed42fb-9a75-485f-9633-c2fbfc090f0d, Sadaba-Echarri, L.M. (Luis Manuel)|||/items/f4df381d-5180-416f-b01c-67598e7d4149, Moreno-Montañes, J. (Javier)|||/items/98d37454-a942-4359-9367-75c9948f0834
Formato: artículo
Fecha de publicación:2002
País:España
Recursos:Universidad de Navarra
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:español
OAI Identifier:oai:dadun.unav.edu:10171/23474
Acesso em linha:https://hdl.handle.net/10171/23474
Access Level:acceso abierto
Palavra-chave:Transpupillary thermotherapy
Choroidal neovascularization
Age-related macular degeneration
Descrição
Resumo:To determine the efficacy of transpupillary thermotherapy (TTT) to treat choroidal neovascularization (CNV) in patients with age-related macular degeneration (ARMD). Patients and Methods: Eight patients (ten eyes) with occult CNV were treated by TTT. A 810 nm diode laser was used to perform TTT. The diode laser was delivered through a panfunduscopic contact lens. Results: Three eyes showed a visual acuity improvement and a decrease in exudation on fluorescein angiography. Four eyes remained stable. Nevertheless, lesions worsened after treatment in three cases. One of these cases suffered an overtreatment. Conclusions: TTT may be a useful therapy in some cases of CNV in patients with age-related macular degeneration. Randomized and multicentric studies are necessary to stablish precise indications of this therapy